IP Library › Assignment 027705/0660
Patent Assignment
Reel/Frame 027705/0660

Assignment of Assignor's Interest

Recorded: 2012-02-15 Received: 2012-02-15 Pages: 6
Assignor
Assignee
SPROUT PHARMACEUTICALS, INC.
4208 SIX FORKS ROAD, SUITE 1010, RALEIGH, NC, 27609, UNITED STATES
Covered Properties (20)
New Salts
Application: 13/131,926 →
Treatment of Vasomotor Symptoms
Application: 12/675,231 →
Pharmaceutical Compositions for the Treatment of Sexual Disorders II
Application: 12/987,388 →
Formulations of Flibanserin
Application: 12/867,097 →
Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity
Application: 12/518,574 →
Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders
Application: 12/532,269 →
Flibanserin for the Treatment of Urinary Incontinence and Related Diseases
Application: 12/306,878 →
Method of Improving Efficacy of Biological Response-Modifying Proteins and the Exemplary Muteins
Application: 12/499,710 →
Use of Flibanserin for the Treatment of Sexual Disorders in Females
Application: 12/306,945 →
Benzimidazolone Derivatives for the Treatment of Premenstrual and Other Female Sexual Disorders
Application: 12/091,848 →
Use of Flibanserin in the Treatment of Obesity
Application: 11/997,567 →
Pharmaceutical compositions for the treatment of sexual disorders II
Application: 11/960,957 →
Use of flibanserin for the treatment of post-menopausal Sexual Desire Disorders
Application: 11/745,515 →
Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
Application: 11/554,855 →
Use of flibanserin for the treatment of post-menopausal Sexual Desire Disorders
Application: 60/830,987 →
Use of flibanserin for the treatment of pre-menopausal Sexual Desire Disorders
Application: 60/831,015 →
Use of flibanserin for the treatment of post-menopausal Sexual Desire Disorders
Application: 60/746,817 →
Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
Application: 60/734,405 →
Pharmaceutical compositions for the treatment of sexual disorders II
Application: 11/110,449 →
New pharmaceutical compositions for the treatment of sexual disorders
Application: 60/564,662 →